51-60 items (total 85)
Published on March 16, 2023
New Method Developed to Evaluate the Efficacy of Poorly Absorbed Antimicrobial Agents- Contributing to the Proper Use of Therapeutics for Clostridioides difficile Infection and Promoting the Development of New Treatments -
Office of Communications and Public Relations
Published on February 02, 2023
Creation of Non-Planar "Porphyrin 2.0"—Anticipating Development Toward Ultra-Functional Molecules Unattainable with Planar Compounds
Office of Communications and Public Relations
Published on February 02, 2023
An Interview with Professor Kim Yoon-gi Published in *Business Insider Japan*.
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published on December 23, 2022
Newly Developed Multilayered Human Skeletal Muscle Tissue Model and Contractile Force Measurement System Useful for Myopathy Research
Office of Communications and Public Relations
Published on December 19, 2022
Development of a New Structural Analysis Method to Identify the Double Bond Positions in Lipids: Contributing to the Elucidation of Lipid Metabolism Mechanisms with Mass Spectrometry and Data Science
Office of Communications and Public Relations
Published on December 07, 2022
Demonstration of High-Accuracy Differentiation of 13 Cancer Types Using Blood microRNAs—Release of the World's Largest Human Serum microRNA Database—
Office of Communications and Public Relations
Published on November 11, 2022
A feature on the Keio University Faculty of Pharmacy has been published in *The Encyclopedia of Medical School Admissions, 2023 Definitive Edition* (President Inc.).
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published on November 01, 2022
An interview with Professor Juichi Otani was published in *Turn Up*, no. 59 (Pharmasy Co., Ltd.).
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published on October 25, 2022
Measurement of Red Blood Cell Parameters and BRCA1/2 Gene Mutations Before Treatment Can Predict Severe Anemia Caused by Olaparib, a Standard Cancer Therapy - A Step Toward Early Detection and Treatment Management of "High-Risk Patients" -
Office of Communications and Public Relations
Published on October 19, 2022
An interview with Associate Professor Juntaro Matsuzaki, “Developing Strategies to Control COVID-19 Using Extracellular Vesicles,” is now available on the website of the Chemo-Sero-
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences